Some research calls into question the effectiveness of frequent prostate cancer screenings. Apparently there’s not much difference between two- and four-year tests. Robert Preidt of HealthDay News explains:
The researchers looked at more than 17,000 men who had prostate specific antigen (PSA) testing every two years or every four years. Among 4,202 Swedish men screened every two years, the overall incidence of prostate cancer diagnosis over 10 years was 13.14 percent, compared to 8.41 percent among the 13,301 Dutch men who were screened every four years, said the researchers from Erasmus Medical Centre in Rotterdam, The Netherlands.Wait! A money-making medical test might not actually be as good as they say it is—no! You’re joshing me. Dr. Fuhrman is hardly awed by PSA screenings. He shares his thoughts in a previous post:
The total number of interval cancers -- those diagnosed based on symptoms during the years between screening tests -- was 31 (0.74 percent) among the Swedish men and 57 (0.43 percent) among the Dutch men.
The differences in the interval cancer rates and aggressive interval cancer rates between the two groups were not statistically significant, the study authors said. This indicates that two-year screenings don't reduce the number of interval cancers, as might be expected.
Incredible as it may seem, the PSA test does not accurately detect cancer. If you are over 60 years old, the chance of having a prostate biopsy positive for cancer is high, and the likelihood you have prostate cancer is the same whether or not you have an elevated PSA. More and more studies in recent years have demonstrated that prostate cancer is found at the same high rate in those with lower, so-called “normal” PSAs as those with elevated PSAs.1 An interesting study from Stanford University in California showed that the ability of PSA to detect cancer from 1998 to 2003 was only 2 percent. The elevations in PSA (between 2 and 10) were related to benign enlargement of the prostate, not cancer.Here’s the entire post: Positively False Confidence in PSA Tests.
Remember, the pharmaceutical/medical industry is big business. Too often, treatments are promoted from a financially-biased perspective, leading to overly invasive and aggressive care without documented benefits.